Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Cell, 2026
A comparison of deep multiomics profiles across ethnicity, geography, and age

Barapour N., Cao J., Wu Y. et al.

Olink Target 96Wider Proteomics StudiesPathophysiologyPatient StratificationPlasma

JID Innovations, 2026
Activation of MyD88/IRAK1 axis and downstream proinflammatory signaling in healthy adult and neonatal African American skin

Trubetskoy D., Grudzien P., Klopot A. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesDermatological DiseasesPatient StratificationTissue Lysate

Resuscitation Plus, 2026
Gene-set and proteomic signatures associated with survival after in-hospital cardiac arrest

Patel J., Parnia S., Ichinose F. et al.

Olink Explore 3072/384CVDPathophysiologyPatient StratificationPlasma

Clinical Nutrition ESPEN, 2026
Effect of different sources of saturated and polyunsaturated fatty acids on postprandial inflammation: A double-blind randomized crossover trial

Limani N., Henriksen H., Minge M. et al.

Olink Target 96CVDNutritional SciencePathophysiologyPlasma

Journal of Advanced Research, 2026
ProtPhenoAge: Integrating plasma proteomics to predict Aging-Related disease Risks

Wang Y., Sun Y., Yang F. et al.

Olink Explore 3072/384AgingPathophysiologyPatient StratificationPlasma

Gastric Cancer, 2026
Plasma proteomic signatures improve risk stratification and personalized screening for gastric cancer

Li X., Shi W., Zhu J. et al.

Olink Explore 3072/384OncologyCross-platform ValidationPlasma

Cell Communication and Signaling, 2026
Periprostatic adipose tissue-derived adipokine profile in prostate cancer patients reveals two distinct molecular phenotypes linked to obesity-related comorbidities: multifaceted role of lipocalin-2

Pérez-Gómez J., Prats-Escribano A., Gil-Duque I. et al.

Olink Target 96OncologyPathophysiologyCell Culture Supernatant

Medicine, 2026
Mendelian randomization analysis links HLA-DR+ CD14− CD16+ monocytes to CCL19-driven ankylosing spondylitis risk

Bei L., Liao J., Tan C. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Medicine, 2026
Potential therapeutic targets for multisite chronic pain: A proteome-wide Mendelian randomization study

Gao J., Liu J.

Olink Explore 3072/384NeurologyPathophysiologyPlasma

Liver International, 2026
Systemic Inflammation and Peripheral T Cell Responses Associate With Hepatic Energy Metabolism in Recent‐Onset Type 1 Diabetes

Ratter‐Rieck J., Zepina A., Huttasch M. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasmaCell Culture Supernatant

Frontiers in Immunology, 2026
Diagnostic value of inflammatory biomarkers of IgA vasculitis based on Olink technology

Huang J., Zhang Z., Wang N. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

Molecular Neurobiology, 2026
Comparative Analysis of Mouse CSF Proteins in Experimental Autoimmune Encephalomyelitis Model and Cuprizone-Induced Demyelination Model by Olink Proteomics

Bernaerts E., Rutten M., De Visscher A. et al.

Olink Target 96 MouseNeurologyPathophysiologyMouse Csf

GeroScience, 2026
Multiorgan transcriptomics and circulating extracellular vesicle profiling reveal age-dependent systemic vulnerability to isoflurane anesthesia and surgery

Krishnamachary B., Lee H., Wang Z. et al.

Olink Target 96 MouseAgingSurgical ComplicationsPathophysiologyMouse EV Lysate

RMD Open, 2026
Cardiovascular health and osteoarthritis risk: a prospective cohort study with proteomic insights from UK Biobank

Luo J., Chen X., Chen N. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesCVDPathophysiologyPlasma

Briefings in Bioinformatics, 2026
StackAge: an ensemble-based clock for precise quantification of biological age using multi-omics data

Jiang Y., Jia L., Fei Y. et al.

Olink Explore 3072/384Wider Proteomics StudiesAgingPathophysiologyPlasma

Clinical and Translational Medicine, 2026
Investigations into the aetiopathogenesis of orofacial granulomatosis using multiple omics technologies reveal a potential role for B cells

Tumelty M., Patel K., Petersen H. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySaliva

Journal of Thrombosis and Haemostasis, 2026
Development of novel plasma proteomic biomarkers for cancer-associated thrombosis in an advanced cancer cohort

Preeti P., Ranjan M., Pham D. et al.

Olink Explore HTOncologyHematologyPatient StratificationPlasma

Cardiovascular Therapeutics, 2026
Genetic Evidence Linking Inflammatory Cytokines and Blood Metabolites to Heart Failure Risk

Yao Y., Tang L., Zhou P. et al.

Olink Target 96CVDPathophysiologyPlasma

European Journal of Endocrinology, 2026
Targeted Proteomics Reveals Novel Biomarkers of Disease Activity and Inflammation in Acromegaly

Godang K., Wessel M., Khan Y. et al.

Olink Target 96EndocrinologyPatient StratificationPlasma

Clinica Chimica Acta, 2026
Emerging biomarkers in IgA nephropathy, membranous nephropathy, and lupus nephritis

Kobayashi H., Murata Y., Akiya Y. et al.

Olink FocusImmunological & Inflammatory DiseasesNephrologyPathophysiologySerum

4265 publications